Effect of Vascular Endothelial Growth Factor and Erythropoietin on Functional Activity of Fibroblasts and Multipotent Mesenchymal Stromal Cells
- 作者: Bondarenko N.1,2, Nikonorova Y.1, Surovtseva M.1, Lykov A.1,2, Poveshchenko O.1,2, Poveshchenko A.1,2, Pokushalov E.2, Romanov A.2, Konenkov V.1,2
-
隶属关系:
- Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences
- E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
- 期: 卷 160, 编号 4 (2016)
- 页面: 498-501
- 栏目: Experimental Biology
- URL: https://journals.rcsi.science/0007-4888/article/view/236755
- DOI: https://doi.org/10.1007/s10517-016-3206-8
- ID: 236755
如何引用文章
详细
The study examined the effect of VEGF and erythropoietin on proliferative and migratory activities of skin fibroblasts and multipotent mesenchymal stromal cells of human adipose tissue. VEGF stimulated proliferation and migration of fi broblasts, but produced no significant effect on functional activity of multipotent mesenchymal stem cells. Erythropoietin stimulated proliferation of both cell types, but did not affect their migration.
作者简介
N. Bondarenko
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
编辑信件的主要联系方式.
Email: bond802888@yandex.ru
俄罗斯联邦, Moscow; Novosibirsk
Yu. Nikonorova
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences
Email: bond802888@yandex.ru
俄罗斯联邦, Moscow
M. Surovtseva
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences
Email: bond802888@yandex.ru
俄罗斯联邦, Moscow
A. Lykov
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
俄罗斯联邦, Moscow; Novosibirsk
O. Poveshchenko
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
俄罗斯联邦, Moscow; Novosibirsk
A. Poveshchenko
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
俄罗斯联邦, Moscow; Novosibirsk
E. Pokushalov
E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
俄罗斯联邦, Novosibirsk
A. Romanov
E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
俄罗斯联邦, Novosibirsk
V. Konenkov
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
俄罗斯联邦, Moscow; Novosibirsk
![](/img/style/loading.gif)